These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 14639613

  • 1. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
    Lukanova A, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Arslan AA, Rinaldi S, Muti P, Lenner P, Koenig KL, Biessy C, Krogh V, Riboli E, Shore RE, Stattin P, Berrino F, Hallmans G, Toniolo P, Kaaks R.
    Int J Cancer; 2004 Jan 10; 108(2):262-8. PubMed ID: 14639613
    [Abstract] [Full Text] [Related]

  • 2. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
    Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli E.
    J Natl Cancer Inst; 2000 Oct 04; 92(19):1592-600. PubMed ID: 11018095
    [Abstract] [Full Text] [Related]

  • 3. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer.
    Keinan-Boker L, Bueno De Mesquita HB, Kaaks R, Van Gils CH, Van Noord PA, Rinaldi S, Riboli E, Seidell JC, Grobbee DE, Peeters PH.
    Int J Cancer; 2003 Aug 10; 106(1):90-5. PubMed ID: 12794762
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
    Lacey JV, Potischman N, Madigan MP, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lurain JR, Fillmore CM, Sherman ME, Brinton LA.
    Cancer Epidemiol Biomarkers Prev; 2004 Apr 10; 13(4):607-12. PubMed ID: 15066926
    [Abstract] [Full Text] [Related]

  • 5. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES, Holly JM, Pollak MN, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev; 2005 Mar 10; 14(3):699-704. PubMed ID: 15767352
    [Abstract] [Full Text] [Related]

  • 6. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.
    Wei EK, Ma J, Pollak MN, Rifai N, Fuchs CS, Hankinson SE, Giovannucci E.
    Cancer Epidemiol Biomarkers Prev; 2005 Apr 10; 14(4):850-5. PubMed ID: 15824155
    [Abstract] [Full Text] [Related]

  • 7. A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women.
    Lukanova A, Toniolo P, Akhmedkhanov A, Biessy C, Haley NJ, Shore RE, Riboli E, Rinaldi S, Kaaks R.
    Int J Cancer; 2001 Jun 15; 92(6):888-92. PubMed ID: 11351312
    [Abstract] [Full Text] [Related]

  • 8. Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy).
    Lukanova A, Lundin E, Micheli A, Akhmedkhanov A, Rinaldi S, Muti P, Lenner P, Biessy C, Krogh V, Riboli E, Hallmans G, Berrino F, Zeleniuch-Jacquotte A, Toniolo P, Kaaks R.
    Cancer Causes Control; 2003 Apr 15; 14(3):285-92. PubMed ID: 12814208
    [Abstract] [Full Text] [Related]

  • 9. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.
    Oh JC, Wu W, Tortolero-Luna G, Broaddus R, Gershenson DM, Burke TW, Schmandt R, Lu KH.
    Cancer Epidemiol Biomarkers Prev; 2004 May 15; 13(5):748-52. PubMed ID: 15159305
    [Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE.
    Endocr Relat Cancer; 2006 Jun 15; 13(2):583-92. PubMed ID: 16728584
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition.
    Cust AE, Allen NE, Rinaldi S, Dossus L, Friedenreich C, Olsen A, Tjønneland A, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Linseisen J, Chang-Claude J, Boeing H, Schulz M, Benetou V, Trichopoulou A, Trichopoulos D, Palli D, Berrino F, Tumino R, Mattiello A, Vineis P, Quirós JR, Agudo A, Sánchez MJ, Larrañaga N, Navarro C, Ardanaz E, Bueno-de-Mesquita HB, Peeters PH, van Gils CH, Bingham S, Khaw KT, Key T, Slimani N, Riboli E, Kaaks R.
    Int J Cancer; 2007 Jun 15; 120(12):2656-64. PubMed ID: 17285578
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls.
    Rutanen EM, Stenman S, Blum W, Kärkkäinen T, Lehtovirta P, Stenman UH.
    J Clin Endocrinol Metab; 1993 Jul 15; 77(1):199-204. PubMed ID: 7686914
    [Abstract] [Full Text] [Related]

  • 15. A prospective study of plasma C-peptide and colorectal cancer risk in men.
    Ma J, Giovannucci E, Pollak M, Leavitt A, Tao Y, Gaziano JM, Stampfer MJ.
    J Natl Cancer Inst; 2004 Apr 07; 96(7):546-53. PubMed ID: 15069117
    [Abstract] [Full Text] [Related]

  • 16. Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: a prospective study in northern Sweden.
    Palmqvist R, Stattin P, Rinaldi S, Biessy C, Stenling R, Riboli E, Hallmans G, Kaaks R.
    Int J Cancer; 2003 Oct 20; 107(1):89-93. PubMed ID: 12925961
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
    Stattin P, Bylund A, Rinaldi S, Biessy C, Déchaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R.
    J Natl Cancer Inst; 2000 Dec 06; 92(23):1910-7. PubMed ID: 11106682
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
    Rinaldi S, Kaaks R, Zeleniuch-Jacquotte A, Arslan AA, Shore RE, Koenig KL, Dossus L, Riboli E, Stattin P, Lukanova A, Toniolo P.
    Cancer Epidemiol Biomarkers Prev; 2005 Jan 06; 14(1):48-52. PubMed ID: 15668475
    [Abstract] [Full Text] [Related]

  • 20. Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women with endometrial cancer.
    Ayabe T, Tsutsumi O, Sakai H, Yoshikawa H, Yano T, Kurimoto F, Taketani Y.
    Endocr J; 1997 Jun 06; 44(3):419-24. PubMed ID: 9279518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.